Avanos Medical
AVNS
328 hedge funds and large institutions have $1.69B invested in Avanos Medical in 2017 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 86 increasing their positions, 114 reducing their positions, and 39 closing their positions.
3% more capital invested
Capital invested by funds: $1.64B → $1.69B (+$48.8M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2% less funds holding
Funds holding: 335 → 328 (-7)
15% less first-time investments, than exits
New positions opened: 33 | Existing positions closed: 39
25% less repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 114
36% less call options, than puts
Call options by funds: $1.71M | Put options by funds: $2.65M
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$49.9M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$28.3M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$19.2M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$16.7M |
| 5 |
JP Morgan Chase
New York
|
+$6.39M |
Top Sellers
| 1 |
SCM
Shapiro Capital Management
Atlanta,
Georgia
|
-$50.5M |
| 2 |
BlackRock
New York
|
-$24.2M |
| 3 |
HCM
Hodges Capital Management
Dallas,
Texas
|
-$16.9M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$8.6M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$8.6M |
AVNS Hedge Fund Activity: Q2 2017 in Review
328 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q2 2017, worth a combined $1.69B — up 3% from $1.64B a quarter earlier.
Sellers outnumbered buyers: 39 funds closed out of AVNS and 33 opened new positions — a net loss of 6 holders — while 114 trimmed existing stakes and 86 added.
The largest buyer was Goldman Sachs, adding an estimated $49.9M. The largest seller was Shapiro Capital Management, exiting entirely with an estimated $50.5M sold.
- 328 institutional investors held Avanos Medical (AVNS) as of Q2 2017, down from 335 in Q1 2017.
- Funds reported $1.69B of Avanos Medical stock for Q2 2017, up 3% quarter-over-quarter.
- 33 funds opened new Avanos Medical positions in Q2 2017 and 39 closed out, a net change of -6 holders.
- The largest Avanos Medical buyer in Q2 2017 was Goldman Sachs, an estimated $49.9M added.
- The largest Avanos Medical seller in Q2 2017 was Shapiro Capital Management, an estimated $50.5M sold.
Based on aggregated 13F filings for Q2 2017.